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Summary 
The molecular nature of cell adhesion mediated by platelet/endothelial  cell adhesion molecule 
1 (PECAM-1;  CD31)  was examined  using  stably transfected L  ceils  in  a PECAM-dependent 
aggregation assay. This adhesion was temperature sensitive and divalent cation dependent, with 
Mg  2§  supporting aggregation to a greater degree than Ca  2  +.  PECAM-dependent  aggregation 
was heterophilic:  PECAM-1  transfectants bound as readily to control-transfected L cells as to 
other PECAM-1  transfectants,  demonstrating  that  a molecule endogenously expressed on the 
L cells serves as the ligand for PECAM in this system and presumably substitutes for the natural 
human  ligand. 
p latelet/endothelial cell adhesion molecule I  (PECAM-1; 
CD31)  is a member of the Ig gene superfamily of cell 
adhesion molecules (CAMs) (1). It is an integral membrane 
glycoprotein expressed by all continuous human endothelia 
in situ (2) and by platelets and cells of myeloid lineage (3-5). 
Previous studies have suggested that PECAM-1  may func- 
tion in intercellular recognition and/or adhesion between en- 
dothelial cells  (EC) since:  (a)  it was expressed diffusely on 
subconfluent EC but concentrated in the intercellular junc- 
tions when cells contacted each other (2); (b) antibodies against 
PECAM  could  delay  the  formation  of  confluent  EC 
monolayers (6; and Muller, unpublished observations); and 
(c) L cells transfected with  PECAM cDNA  aggregated in 
a PECAM-dependent fashion that was inhibitable with anti- 
PECAM  antibody (7). 
COS cells transiently transfected with PECAM-1 cDNA 
concentrated the molecule at the junctions between cells ex- 
pressing the molecule, but not at junctions between trans- 
fected and nontransfected  cells  nor  at  the free cell borders 
(7). This strongly suggested a homophilic adhesion mecha- 
nism in which PECAM-1 served as both ligand and receptor. 
The calcium dependence of PECAM-mediated aggregation 
(7) is unusual for a member of the Ig supergene family, espe- 
cially for one mediating homophilic aggregation,  although 
precedence for such a mechanism  has been established in a 
related molecule of the carcinoembryonic antigen family (8). 
To further  characterize  the nature  of PECAM-mediated 
adhesion,  we studied aggregation  of PECAM-l-transfected 
L cells, a cellular system in which the adhesion events of aggre- 
gation can be studied in isolation from other adhesion events 
involved in binding  to substratum  or extracellular  matrix. 
Materials  and Methods 
Cell Culture.  L cells stably transfected with PECAM-1 cDNA 
were cultured in DME supplemented with 10% FCS and 0.5 mg/ml 
G418 (Gibco Laboratories, Grand Island, NY). Stable L cell trans- 
fectants expressing L-CAM were the generous gift of Dr. Kathryn 
Crossin  (The Rockefeller University). 
PECAM-1 Transfectants.  The PECAM-l-transfected L cell lines 
A and SA, as well as the control  transfectant line (Neo) bearing 
neomycin resistance only, have been previously described (7). Line 
SA cells were derived from line A by FACS  |  (Becton Dickinson 
& Co., Mountain View, CA) of high PECAM expressors. In these 
lines, PECAM and neomycin resistance were cotransfected on sep- 
arate plasmids. 
Lines B1 and D6 were made with PECAM-1 and neomycin re- 
sistance  on  the  same  plasmid. PECAM  was  subcloned  into 
pcDNAI/Neo (Invitrogen, San Diego, CA) at the HindlII site by 
excising PECAM cDNA from the original pGEM7 vector (1) and 
ligating  on synthetic HindIII sites. Unique BamHI sites in both 
PECAM and the vector allowed unambiguous  determination  of 
the orientation  of the PECAM insert.  Stable L cell transfectants 
were made by electoporation of L cells (0.5 ml at 2  x  10Vml in 
DME) with 20/~g linearized plasmid in a gene pulser (Bio-Rad 
Laboratories, Richmond, CA) at 250 mV, 960/~F, 4-mm path length 
cuvettes. After 2 d in nonselective medium (DME  +  10% FCS), 
transfectants were selected by addition of the neomycin analogue 
G418 to a final concentration  of 0.5 mg/ml.  Neomycin-resistant 
colonies were picked 10-14 d later, expanded, and tested for PECAM 
expression by immunofluorescence microscopy using mAb hec7 (2). 
Line B1 contains the PECAM cDNA in the sense orientation;  line 
D6 contains PECAM in the antisense orientation  and is used as 
a negative control. 
Aggregation of L Cell Transfectants.  The aggregation assay was 
performed and quantitated  as previously described (7). In certain 
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cein diacetate succinimide ester (CFSE; Molecular Probes, Eugene, 
OR.) (9). Transfectants in 80-ram culture dishes were washed three 
times  in HBSS,  then incubated at 37~  for 10 rain in 10 ml of 
33/~M CFSE in HBSS (diluted  from 10 mM stock in DMSO). 
After  incubation,  cells were  washed  twice  in  HBSS,  then 
resuspended  and processed  as described  (7). 
In experiments  to determine whether aggregation was heter- 
ophilic  or homophilic, two populations of cells, one labeled  and 
the other unlabeled,  were resuspended  at 2  x  106 cells/ml,  and 
0.5-ml aliquots  combined in the wells of a 24-well tissue culture 
tray. After the aggregation  assay  was complete, the cells were viewed 
and photographed under UV light with fluorescein  filters using 
a Nikon Microphot equipped with a UFX-II camera system. Quan- 
titative analysis of the aggregating cell populations was performed 
as described  (10). 
FACS |  Analysis.  L cell transfectants  were nonenzymatically 
resuspended in 10 mM EDTA/HBSS, washed twice in cold HBSS, 
and resuspended  in  to  a  final  concentration of 2  x  106/ml  in 
200/xl HBSS containing 10/~1 hec7  anti-PECAM mAb culture 
supernate  (2) or isotype-matched mAb as a negative control (final 
concentration  of mAb, ,~3/~g/ml). Cells were incubated in 96-well 
round-bottomed culture trays (Coming, Coming, NY) at 4~  for 
30  rain,  washed  three  times  in  HBSS  by  centrifugation,  and 
resuspended  in  fluoresceinated  F(ab')2  fragments  of  rabbit 
anti-mouse IgG (Dako, Santa Barbara, CA) diluted 1:50 in HBSS. 
The incubation and washing steps were repeated,  and the washed 
cells were analyzed  on a FACScan  |  using Consort 30 software. 
Results and Discussion 
Several different lines of PECAM-1 transfectants were used 
in these studies; all express PECAM-1 within the physiologic 
range. Control transfectants (Neo) showed no surface PECAM 
detectable by FACScan  |  (Fig. 1 a), while the PECAM-1 trans- 
fectants displayed their characteristic and reproducible fluores- 
cence profiles with PECAM staining intensity of B1 <  A < 
SA. Under the staining conditions used here, human umbil- 
ical vein endothelial ceUs  from confluent cultures have a mean 
fluorescence channd number of "d00 (data  not shown). 
Cation Dependence of PECAM-1 Aggregation.  We previ- 
ously reported that PECAM-dependent aggregation of trans- 
fected L cells required physiologic concentrations of calcium 
(7). Since a divalent cation requirement for adhesion medi- 
ated by an Ig superfamily molecule is unusual (the notable 
exceptions being VCAM and ICAM that have as their ligands 
B1 and B2 integrins, respectively [11, 12]), we set out to fur- 
ther investigate the divalent cation dependence of the aggre- 
gation mediated by PECAM-1. 
Substitution of magnesium (1 raM) for calcium (1 mM) 
in the aggregation assay led to a 15-40%  greater aggrega- 
tion of PECAM transfectants by 30 min in four separate ex- 
periments. Aggregation in the presence  of magnesium, as 
for calcium (7), was blocked by antibody against  PECAM 
(data not shown). Manganese caused a nonspecific aggrega- 
tion of cells, including control transfectants,  that was not 
blocked by anti-PECAM antibodies. 
Aggregation of  PECAM-I  7~ansfectants  Is Temperature  Sensi- 
tive.  Aggregation of PECAM-expressing transfected L cells 
occurred readily at 37~  but not at 4~  (Fig. 1 b). Control 
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Figure  1.  (a) Quantitation of 
PECAM-1 surface expression by 
independently derived  L cell trans- 
fectants.  PECAM  transfectant 
lines B1, A, and SA, and control 
transfectant line Neo were nonen- 
zymaticaUy  resuspended and ana- 
lyzed for  surface expression of 
PECAM. Fluorescence intensity 
histograms  reveal reproducible 
profies with PECAM expression 
by B1 < A < SA. (b) PECAM-1- 
mediated aggregation is temper- 
ature sensitive. The aggregation 
assay was carried out on resus- 
pended PECAM  transfectants (B1, 
SA) or matching control trans- 
fectants  (D6, Neo)  at  37~ 
(solid lines) or 4~  (broken lines). 
Whereas transfectants expressing 
PECAM  aggregate readily  at 
37~  only background levels of 
aggregation are displayed by the 
controls. No aggregation of any 
cell line is seen at 4~  SD of  mea- 
surements was <5%. 
cells did not aggregate significantly  at either temperature. 
The temperature dependence of aggregation is similar to that 
exhibited by integrins and cadherins (13), and dearly different 
from the temperatureqnsensitive nature of  binding mediated 
by selectins  (14). 
Aggregation  Mediated by PECAM-I Is Heterophilia  To define 
whether adhesion in this system was homophilic or heter- 
ophilic, we performed a mixing experiment similar to that 
used for other CAMs (13, 15). L cells transfected  with the 
neomycin resistance gene only (Neo) or with PECAM-1 in 
the antisense orientation (D6) were vitally labeled with the 
fluorescent  dye CFSE and mixed with an equal number of 
unlabeled PECAM-expressing transfectants  in the standard 
aggregation assay. Aggregates were removed after 30-45 min 
and examined by fluorescence microscopy. A homophilic  adhe- 
sion mechanism  would produce only aggregates of transfected 
(unlabeled) cells. On the other hand, a heterophilic-adhesive 
mechanism, wherein PECAM-1 binds to a different mole- 
Figure  2.  PECAM-l-mediated 
aggregation  is  heterophilic. 
PECAM-transfected L cells were 
mixed with  equal numbers of 
CFSE-labeled control transfectants 
in the  aggregation  assay for 30 
rain at 37~  This micrograph is 
a composite  overlay  of a typical  ag- 
gregate viewed  under phase  contrast and fluorescence  optics. Cells expressing 
PECAM bind to those that do not. Nontransfeeted cells are frequently 
seen at the edges  of aggregates indicating that they are not nonspecifically 
trapped in these cell clusters. Identical  results are obtained when PECAM 
transfeetants are the cell population  bearing the CFSE  label. Bar =  100/*m. 
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Figure  3.  Quantification of heterophilic  aggregation.  Control trans- 
fected cells (line D6) were labeled with CFSE and mixed with equal numbers 
of PECAM transfectants  (line B1) or L-CAM transfectants  in an experi- 
ment similar to the one performed for Fig. 2. Aggregates  at 45 min were 
examined by fluorescence  microscopy. This figure compares randomly chosen 
aggregates of five ceils observed in both the PECAM and L-CAM samples. 
The histograms show the number of aggregates bearing increasing numbers 
of the specific transfected  cell type.  The L-CAM sample distribution is 
skewed far to the right, as expected for a homophilic aggregation,  whereas 
the PECAM sample shows a unimodal peak just to the right of center, 
as expected for a heterophilic aggregation mechanism (10) in which PECAM 
transfectants  can bind equally well to transfected or nontransfected  cells. 
Skewing just to the right of the midline stems from the higher probability 
of nucleating an aggregate with a transfected (PECAM-l-expressing)  cell. 
In nonmathematical  terms,  if the first cell in the nascent  aggregate  ex- 
presses PECAM, then the next cell to join the aggregate  may be trans- 
fected or not if binding is heterophilic.  However, if the first cell is non- 
transfected, the next cell must be transfected (PECAM expressing) in order 
to bind and continue the growth of the aggregate. 
cule on the apposing cell, would produce mixed aggregates 
of transfected (unlabeled) and nontransfected (labeled)  cells. 
The results of such an experiment (Fig.  2) showed that 
aggregation was clearly heterophilic,  with nontransfected cells 
positively identified in aggregates by virtue of their bright 
fluorescence.  Anti-PECAM  antibody  markedly  inhibited 
aggregation in this system, as previously shown (7). 
The heterophilic nature of this aggregation was consistently 
observed in all three lines  of PECAM transfectants. How- 
ever, to control for our ability to detect a homophilic adhe- 
sion mechanism if one were occurring, we compared in par- 
allel the aggregation of L cells transfected with the liver cell 
adhesion  molecule  L-CAM  (the  chicken  equivalent  of 
E-cadherin) (16) and those transfected with PECAM. L-CAM 
mediates  calcium-dependent  homophilic  adhesion  (17). 
L-CAM-expressing cells aggregated in a clearly homophilic 
manner,  with  >80%  of the  aggregates  containing  only 
L-CAM transfectants, and the majority of the rest containing 
only one nontransfected cell. In contrast, the PECAM trans- 
fectants formed mixed aggregates with controls, as previously 
observed. Fig. 3 shows the results for aggregates of five cells 
in this experiment, but is typical of the results for all sizes 
examined (3  to >20 cells). 
The characteristics of PECAM-mediated adhesion described 
in this report are intrinsic features of the adhesion molecule, 
since transfected cells derived from different parental L cell 
lines using different vectors behaved identically in these ex- 
periments. The ligand for PECAM in this system must be 
a molecule(s) for which endogenous surface components of 
(murine) L cells can substitute. This opens up the possibility 
that cells not bearing PECAM can interact with PECAM 
on endothelium or leukocytes in vivo. The temperature and 
divalent cation dependence, and the precedent set by the other 
vascular CAMs of the Ig superfamily, ICAM-1 and VCAM-1, 
suggest that the ligand for PECAM-1 could be an integrin. On 
the other hand, the second Ig loop of PECAM contains a 
consensus glycosaminoglycan recognition sequence (LKREKN) 
(1, 5, 7, 18), suggesting that PECAM, like neural cell adhesion 
molecule (N-CAM), which has a similar sequence at the same 
site (19),  could bind a glycosaminoglycan moiety (20). 
Identification of a heterophilic adhesion mechanism for 
PECAM-1 was somewhat surprising in view of our results 
showing that PECAM was localized exclusively at borders 
between PECAM-transfected COS cells (7), a finding that 
suggested homophilic adhesion. However, this does not rule 
out the possibility that PECAM-1 could mediate homophilic 
adhesion under different conditions. Dual homophilic/het- 
erophilic adhesion has been demonstrated for neuron-glia cell 
adhesion molecule (Ng-CAM) (21). The aggregation assay 
is a short-term reaction in which hydrodynamic forces tend 
to push the suspended cells together. In contrast, cells in cul- 
ture have hours to days in which molecules on apposing mem- 
branes may reorganize to create the most stable adhesion. It 
is possible, for example, that the initial contact of endothelial 
cells  with  each  other  involves  heterophilic  adhesion  via 
PECAM-1, which sorts out into homophilic adhesion as the 
cells become more closely apposed. 
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